全文获取类型
收费全文 | 8112篇 |
免费 | 664篇 |
国内免费 | 471篇 |
专业分类
耳鼻咽喉 | 15篇 |
儿科学 | 26篇 |
妇产科学 | 28篇 |
基础医学 | 219篇 |
口腔科学 | 77篇 |
临床医学 | 343篇 |
内科学 | 232篇 |
皮肤病学 | 119篇 |
神经病学 | 158篇 |
特种医学 | 167篇 |
外科学 | 201篇 |
综合类 | 1344篇 |
预防医学 | 205篇 |
眼科学 | 56篇 |
药学 | 5045篇 |
15篇 | |
中国医学 | 873篇 |
肿瘤学 | 124篇 |
出版年
2024年 | 23篇 |
2023年 | 50篇 |
2022年 | 134篇 |
2021年 | 189篇 |
2020年 | 190篇 |
2019年 | 130篇 |
2018年 | 169篇 |
2017年 | 211篇 |
2016年 | 250篇 |
2015年 | 277篇 |
2014年 | 583篇 |
2013年 | 595篇 |
2012年 | 701篇 |
2011年 | 734篇 |
2010年 | 569篇 |
2009年 | 420篇 |
2008年 | 511篇 |
2007年 | 519篇 |
2006年 | 456篇 |
2005年 | 392篇 |
2004年 | 365篇 |
2003年 | 299篇 |
2002年 | 221篇 |
2001年 | 182篇 |
2000年 | 178篇 |
1999年 | 132篇 |
1998年 | 78篇 |
1997年 | 110篇 |
1996年 | 84篇 |
1995年 | 74篇 |
1994年 | 47篇 |
1993年 | 41篇 |
1992年 | 39篇 |
1991年 | 25篇 |
1990年 | 22篇 |
1989年 | 15篇 |
1988年 | 18篇 |
1987年 | 24篇 |
1986年 | 21篇 |
1985年 | 16篇 |
1984年 | 17篇 |
1983年 | 17篇 |
1982年 | 19篇 |
1981年 | 11篇 |
1980年 | 15篇 |
1979年 | 17篇 |
1978年 | 12篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1973年 | 9篇 |
排序方式: 共有9247条查询结果,搜索用时 15 毫秒
1.
一阶导数高速脉冲极谱法用于盐酸普鲁卡因的定量分析 总被引:2,自引:0,他引:2
研究了一阶导数高速脉冲极谱法,并运用于盐酸普鲁卡因及其注射制剂的定量分析。在-0.04 V(对 Ag/AgCl)处出现的良好导数峰,于1.0~6.0×10~(-4)mol/L 范围内,导数峰电流与浓度呈线性关系。检测限为3.0×10~(-8)mol/L。操作简便、快速、灵敏,结果准确。 相似文献
2.
目的:观察长托宁作为全麻病人麻醉前用药对心血管系统和呼吸道分泌物的影响.方法:随机选择20例需全麻手术病人,在麻醉诱导前静注长托宁0.015 mg/kg,观察注药前、后5、10、20分钟各时点的血压、心率、脉搏氧饱和度及口干程度以及术中术毕口腔和呼吸道分泌物情况.结果:病人使用长托宁后5、10、20分钟的血压、心率与使用前相比有下降趋势,但无统计学意义(P>0.05),脉搏氧饱和度未见明显改变,用药10分钟病人有轻度口干,术毕拔除气管导管时口腔及呼吸道分泌物较少.结论:长托宁用于全麻病人麻醉前给药效果满意. 相似文献
3.
4.
5.
Devi Kanikanti Padmalatha Rao Kanikanti V. Ranga Baveja Srikrishan Fathi Marc Roth Marc 《Pharmaceutical research》1989,6(4):313-317
Zero-order release of oxprenolol hydrochloride was obtained by controlling the swelling and erosion of the matrix. This formulation involves only mixing of drug, hydroxypropylmethylcellulose (HPMC), and sodium carboxymethylcellulose (Na CMC) at the ratio of 1:0.4:1.6, respectively, and compressing the mixture directly into tablets. The in vitro release pattern from this optimized matrix tablet was reproducible. Accelerated stability studies revealed that the optimized formulation remains stable for an approximately 2-year shelf life. This sustained-release (SR) tablet was evaluated in dogs, and for comparison a conventional (CV) formulation was also given at the same dose level. Plasma oxprenolol levels were monitored by a sensitive and specific high-performance liquid chromatographic (HPLC) method. Significant differences in the pharmacokinetic parameters, i.e., lower C
max, higher values of t
max, MRT, AUC, and plasma concentration at 24 hr, and nearly constant plasma levels over 12 hr, indicated that the SR matrix tablet is superior to the CV rapid-releasing formulation. The in vitro release parameters and in vivo pharmacokinetics correlated well. 相似文献
6.
Fierro B. Castiglione M. G. Salemi G. Savettieri G. 《The Italian Journal of Neurological Sciences》1987,8(2):167-169
The case of a myasthenia-like syndrome induced by cardiovascular drugs is reported. The clinical and electrophysiological
features of the case are discussed.
Sommario Viene descritto il caso di una sindrome miastenica indotta da farmaci efficaci sul sistema cardiovascolare. Vengono analizzate e discusse le principali caratteristiche cliniche ed elettrofisiologiche del caso.相似文献
7.
Since 1903, Marchiafava‐Bignami disease has been recognized as a rare syndrome with focal demyelination and necrosis in the corpus callosum, which is usually found in chronic alcoholics. It extends into the neighboring white matter and occasionally as far as the subcortical regions. We report a Japanese patient with Marchiafava‐Bignami disease associated with alcohol abuse, who had traveled around Western Europe, North America and China for more than 30 years. As he suffered extreme delirium in the early stages we administered a low dose (10 mg) of mianserin hydrochloride. He was very irritable and uncooperative on admission, after 20 days his delirium had disappeared and his temper had become very calm and mild. After 40 days, his intelligence level increased substantially as measured by various neuropsychological tests. 相似文献
8.
S. Kudo K. Umehara Yoshifumi Abe Masayuki Furukawa Masaaki Odomi 《Psychopharmacology》1997,131(4):388-393
To elucidate the penetrability of carteolol, a β-adrenoceptor antagonist (β-blocker) into the brain of rats, intracerebral
and serum concentrations of the compound were determined in male rats receiving single or repetitive oral administration of
carteolol hydrochloride at 30 mg/kg. The time-course of the intracerebral concentration of carteolol following single IV administration
of the compound at 10 and 30 mg/kg was also studied in male rats. A high-performance liquid chromatography method was used
to determine the intracerebral and serum concentrations. Following single oral dosing, the intracerebral concentration of
carteolol reached a maximum of 0.074 μg/g at 2 h postdosing and declined with a half-life of 3.7 h, and the Cmax and AUC of carteolol in the brain were 12.5% and 19.8% of those in serum. The intracerebral and serum concentrations of carteolol
were determined in male rats receiving repetitive oral dosing of the compound once daily for 7 days. The concentration of
carteolol in the brain and serum at 1 h postdosing varied within a range of 0.059–0.091 μg/g and 0.321–0.443 μg/ml, respectively,
throughout the dosing period, showing no changes in the penetrability of the compound into the brain due to repeated dosing.
The concentration of carteolol in the brain and serum increased in a dose-dependent manner in rats receiving a single IV administration
of the compound. The elimination half-life of carteolol in the serum and brain was 0.6–0.8 h and 1.3–1.7 h, respectively,
in rats following single IV dosing of the compound. The half-life in the brain was about twice as long as that in the serum.
The brain to serum concentration ratio was 0.306:0.499. From the above results, it was concluded that carteolol is distributed
from the circulation to the brain with low penetrability.
Received: 30 October 1996/Final version: 16 December 1996 相似文献
9.
10.
扑苯黄片中三组分的HPLC测定 总被引:1,自引:0,他引:1
用HPLC同时测定扑苯黄片中三组分的含量。采用Spherisorb CN柱,操作简单,结果准确。对乙酰氨基酚、盐酸伪麻黄碱、盐酸苯海拉明的回收率分别为100.3%、99.8%、99.5%,RSD分别为0.29%、0.51%、0.45%。 相似文献